← Back to Clinical Trials
RecruitingNCT06291818

Self-Adhering Magnetic Device to Treat Corneal Exposure

◆ AI Clinical Summary
Plain-language summary for patients

Trial Parameters

ConditionParalytic Lagophthalmos
SponsorUniversity of Illinois at Chicago
Study TypeINTERVENTIONAL
PhaseN/A
Enrollment25
SexALL
Min Age18 Years
Max Age80 Years
Start Date2024-04-17
Completion2024-12-01
Interventions
temporary magnetic system for tarsorrhaphy (MST)

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

Brief Summary

Paralytic lagophthalmos can be difficult to treat and manage. It has a host of causes and effects, one of which (for the latter) is exposure keratopathy. Untreated, this can lead to corneal ulceration, inflammation, and potentially blindness. Despite a variety of attempts at treating this complex condition, none have satisfactorily reduced complications ranging from ease of use to aesthetics. With improvement in magnetic technology, however, that may change. Barmettler et al (2014) have demonstrated preliminary success of externally affixed magnets in closing both model and patient eyelids. As such, we hypothesize that magnetic devices can be used to treat corneal exposure by controlling eyelid position.

Eligibility Criteria

Inclusion Criteria: * Males and females ages 18-80 years old. * Patients with recent corneal abrasion and no signs of infection in the examination * Patients with lagophthalmos * Normal Controls Exclusion Criteria: * Individuals with adhesive or tape allergies. * Individuals with a history of metal pieces/shavings embedded in the eye (such as from welding or metalworking) * Individuals with eye infections

Related Trials